N-(4-cyclopentylphenyl)-N-[2-[2-(3-fluorophenyl)ethylamino]-2-oxo-1-pyridin-3-ylethyl]furan-2-carboxamide
C31H30FN3O3 — CID 156906936
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-(4-cyclopentylphenyl)-N-[2-[2-(3-fluorophenyl)ethylamino]-2-oxo-1-pyridin-3-ylethyl]furan-2-carboxamide
N-(4-cyclopentylphenyl)-N-[2-[2-(3-fluorophenyl)ethylamino]-2-oxo-1-pyridin-3-ylethyl]furan-2-carboxamide (PubChem CID 156906936) has the molecular formula C31H30FN3O3 and a molecular weight of 511.60 g/mol. Its IUPAC name is N-(4-cyclopentylphenyl)-N-[2-[2-(3-fluorophenyl)ethylamino]-2-oxo-1-pyridin-3-ylethyl]furan-2-carboxamide.
Molecular Properties
| Compound Name | N-(4-cyclopentylphenyl)-N-[2-[2-(3-fluorophenyl)ethylamino]-2-oxo-1-pyridin-3-ylethyl]furan-2-carboxamide |
|---|---|
| PubChem CID | 156906936 |
| Molecular Formula | C31H30FN3O3 |
| Molecular Weight | 511.60 g/mol |
| Exact Mass | 511.23 |
| IUPAC Name | N-(4-cyclopentylphenyl)-N-[2-[2-(3-fluorophenyl)ethylamino]-2-oxo-1-pyridin-3-ylethyl]furan-2-carboxamide |
| SMILES | O=C(NCCc1cccc(F)c1)C(c1cccnc1)N(C(=O)c1ccco1)c1ccc(C2CCCC2)cc1 |
| InChI | InChI=1S/C31H30FN3O3/c32-26-10-3-6-22(20-26)16-18-34-30(36)29(25-9-4-17-33-21-25)35(31(37)28-11-5-19-38-28)27-14-12-24(13-15-27)23-7-1-2-8-23/h3-6,9-15,17,19-21,23,29H,1-2,7-8,16,18H2,(H,34,36) |
| InChIKey | FXMUCWQWZQMNSJ-UHFFFAOYSA-N |
| XLogP | 6.22 |
| TPSA | 75.44 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 38 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 511.60 |
| LogP ≤ 5 | 6.22 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 156906936 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.